Published in Am J Physiol Lung Cell Mol Physiol on October 31, 2014
Airway hydration and COPD. Cell Mol Life Sci (2015) 0.94
Role of epithelial sodium channels in the regulation of lung fluid homeostasis. Am J Physiol Lung Cell Mol Physiol (2015) 0.83
Emerging pharmaceutical therapies for COPD. Int J Chron Obstruct Pulmon Dis (2017) 0.83
The Lectin-like Domain of TNF Increases ENaC Open Probability through a Novel Site at the Interface between the Second Transmembrane and C-terminal Domains of the α-Subunit. J Biol Chem (2016) 0.79
Automated acquisition and analysis of airway surface liquid height by confocal microscopy. Am J Physiol Lung Cell Mol Physiol (2015) 0.78
The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis Lung. Mediators Inflamm (2015) 0.78
Oxidized glutathione (GSSG) inhibits epithelial sodium channel activity in primary alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol (2015) 0.78
Glandular Proteome Identifies Antiprotease Cystatin C as a Critical Modulator of Airway Hydration and Clearance. Am J Respir Cell Mol Biol (2016) 0.77
Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis and Other Diseases of Mucus Clearance. Clin Chest Med (2015) 0.76
Current and Emerging Therapies for the Treatment of Cystic Fibrosis or Mitigation of Its Symptoms. Drugs R D (2016) 0.75
The effects of smoking and smoking cessation on nasal mucociliary clearance, mucus properties and inflammation. Clinics (Sao Paulo) (2016) 0.75
Marked increases in mucociliary clearance produced by synergistic secretory agonists or inhibition of the epithelial sodium channel. Sci Rep (2016) 0.75
Differentiation of human bronchial epithelial cells: role of hydrocortisone in development of ion transport pathways involved in mucociliary clearance. Am J Physiol Cell Physiol (2016) 0.75
Finding new drugs to enhance anion secretion in cystic fibrosis: Toward suitable systems for better drug screening. Report on the pre-conference meeting to the 12th ECFS Basic Science Conference, Albufeira, 25-28 March 2015. J Cyst Fibros (2015) 0.75
Interleukin-13 increases pendrin abundance to the cell surface in bronchial NCI-H292 cells via Rho/actin signaling. Pflugers Arch (2017) 0.75
Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest (2002) 5.94
Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci Transl Med (2010) 3.36
Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med (2000) 3.00
The CF salt controversy: in vivo observations and therapeutic approaches. Mol Cell (2001) 2.42
Epithelial sodium channel and the control of sodium balance: interaction between genetic and environmental factors. Annu Rev Physiol (2002) 2.36
Regulation of normal and cystic fibrosis airway surface liquid volume by phasic shear stress. Annu Rev Physiol (2006) 2.33
The relative roles of passive surface forces and active ion transport in the modulation of airway surface liquid volume and composition. J Gen Physiol (2001) 2.28
Soluble mediators, not cilia, determine airway surface liquid volume in normal and cystic fibrosis superficial airway epithelia. J Gen Physiol (2006) 2.24
The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol (2009) 2.23
Neutrophil elastase activates near-silent epithelial Na+ channels and increases airway epithelial Na+ transport. Am J Physiol Lung Cell Mol Physiol (2005) 2.21
Mucins, mucus, and sputum. Chest (2009) 2.09
Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function. Am J Respir Crit Care Med (2013) 1.93
Airway epithelial cells: current concepts and challenges. Proc Am Thorac Soc (2008) 1.90
State of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection? Respir Res (2003) 1.86
Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration. FASEB J (2011) 1.79
Submucosal glands and airway defense. Proc Am Thorac Soc (2004) 1.76
Regulation of airway surface liquid volume by human airway epithelia. Pflugers Arch (2002) 1.66
Preventive but not late amiloride therapy reduces morbidity and mortality of lung disease in betaENaC-overexpressing mice. Am J Respir Crit Care Med (2008) 1.64
Innate immune functions of the airway epithelium. Contrib Microbiol (2008) 1.57
Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy. Am Rev Respir Dis (1990) 1.47
Antimicrobial polypeptides. J Leukoc Biol (2003) 1.46
Genetic determinants of human hypertension. Proc Natl Acad Sci U S A (1995) 1.37
Regulation of the depth and composition of airway surface liquid. J Anat (2002) 1.29
Mucociliary clearance in cystic fibrosis. Pediatr Pulmonol (2002) 1.26
Fluid secretion by submucosal glands of the tracheobronchial airways. Respir Physiol Neurobiol (2007) 1.12
In vivo versus in vitro airway surface liquid nicotine levels following cigarette smoke exposure. J Anal Toxicol (2008) 1.11
Pharmacological properties of N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-4-[4-(2,3-dihydroxypropoxy)phenyl]butyl-guanidine methanesulfonate (552-02), a novel epithelial sodium channel blocker with potential clinical efficacy for cystic fibrosis lung disease. J Pharmacol Exp Ther (2008) 1.11
Acute safety and effects on mucociliary clearance of aerosolized uridine 5'-triphosphate +/- amiloride in normal human adults. Am J Respir Crit Care Med (1996) 1.09
Genotype-phenotype analysis of a newly discovered family with Liddle's syndrome. J Hypertens (1997) 1.07
Does epithelial sodium channel hyperactivity contribute to cystic fibrosis lung disease? J Physiol (2013) 1.05
Measurement of the airway surface liquid volume with simple light refraction microscopy. Am J Respir Cell Mol Biol (2011) 1.04
Altering airway surface liquid volume: inhalation therapy with amiloride and hyperosmotic agents. Adv Drug Deliv Rev (2002) 1.04
Cigarette smoke and CFTR: implications in the pathogenesis of COPD. Am J Physiol Lung Cell Mol Physiol (2013) 0.96
Epithelial mucus-hypersecretion and respiratory disease. Curr Drug Targets Inflamm Allergy (2005) 0.95
Cigarette smoke-induced Ca2+ release leads to cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction. J Biol Chem (2014) 0.93
Effects of drugs on mucus clearance. Eur Respir J (1999) 0.92
Modeling of asthma, COPD and cystic fibrosis in sheep. Pulm Pharmacol Ther (2008) 0.91
Respiratory mucus from asymptomatic smokers is better hydrated and more easily cleared by mucociliary action. Am Rev Respir Dis (1992) 0.91
Methods for ASL measurements and mucus transport rates in cell cultures. Methods Mol Biol (2011) 0.90
Defective adenosine-stimulated cAMP production in cystic fibrosis airway epithelia: a novel role for CFTR in cell signaling. FASEB J (2011) 0.88
Acute hyperkalemia associated with inhalation of a potent ENaC antagonist: Phase 1 trial of GS-9411. J Aerosol Med Pulm Drug Deliv (2013) 0.85
Comparative effects of salmeterol, albuterol, and ipratropium on normal and impaired mucociliary function in sheep. Chest (2005) 0.85
Mechanisms of sodium and chloride transport across equine tracheal epithelium. Am J Physiol (1990) 0.85
The guinea-pig tracheal potential difference as an in vivo model for the study of epithelial sodium channel function in the airways. Br J Pharmacol (2008) 0.83
Gaining the Upper Hand on Pulmonary Drug Delivery. J Pharmacovigil (2014) 0.76